Skip to main content

Select Drug Profiles

Aspirin Safely Omitted from Antithrombotic Therapy in Patients with AF Undergoing PCI
Mary Mosley
Read More
Cardiometabolic Health
Alternative Anticoagulants to Warfarin Reduce Vascular Risk in Patients with NVAF
Wayne Kuznar
Read More
FDA Approvals
Belviq: A New Prescription Weight-Loss Treatment for Overweight or Obese Patients
... .. ...., ....
Read More
Lipid Therapy Update: HDL Therapies Falling Short, Promising LDL Agents, 2 Potential Treatments for Familial Hypercholesterolemia
Wayne Kuznar
Read More
New Prognostic Markers in Hypertension Identified
Mary Mosley
Read More
New Hypertension Guidelines Will Be Strictly Evidence-Based
Wayne Kuznar
Read More
Behavioral Interventions Can Result in Weight Loss
Wayne Kuznar
Read More
FDA Approvals
First-in-Class Angiotensin Receptor Neprilysin Inhibitor Promising in Heart Failure with Preserved Ejection Fraction
Mary Mosley
Read More
FDA Approvals
RELAX-AHF: Serelaxin Reduces Dyspnea in Acute Heart Failure
Mary Mosley
Read More
Cardiometabolic Health
PHS II: Cardiovascular Events in Men Not Reduced with Multivitamins
Mary Mosley
Read More
Page 187 of 244
Results 1861 - 1870 of 2438